Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Year: 2019
Type: letter
Source: New England Journal of Medicine
DOI: 10.1056/nejmc1902837
Author: Piero Baglioni
Institutions: Brigham and Women's Hospital, Prince Charles Hospital
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2980595514
